Trevi Therapeutics Inc (TRVI)
2.94
+0.16
(+5.76%)
USD |
NASDAQ |
Apr 29, 16:00
2.92
-0.02
(-0.68%)
Pre-Market: 20:00
Trevi Therapeutics Price to Book Value: 2.456 for April 29, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 2.456 |
| April 26, 2024 | 2.322 |
| April 25, 2024 | 2.122 |
| April 24, 2024 | 2.214 |
| April 23, 2024 | 2.381 |
| April 22, 2024 | 2.456 |
| April 19, 2024 | 2.368 |
| April 18, 2024 | 2.243 |
| April 17, 2024 | 2.155 |
| April 16, 2024 | 2.226 |
| April 15, 2024 | 2.348 |
| April 12, 2024 | 2.439 |
| April 11, 2024 | 2.490 |
| April 10, 2024 | 2.281 |
| April 09, 2024 | 2.406 |
| April 08, 2024 | 2.619 |
| April 05, 2024 | 2.565 |
| April 04, 2024 | 2.594 |
| April 03, 2024 | 2.640 |
| April 02, 2024 | 2.698 |
| April 01, 2024 | 2.807 |
| March 28, 2024 | 2.882 |
| March 27, 2024 | 2.899 |
| March 26, 2024 | 2.832 |
| March 25, 2024 | 2.799 |
| Date | Value |
|---|---|
| March 22, 2024 | 2.999 |
| March 21, 2024 | 3.091 |
| March 20, 2024 | 2.957 |
| March 19, 2024 | 2.862 |
| March 18, 2024 | 2.688 |
| March 15, 2024 | 2.771 |
| March 14, 2024 | 2.589 |
| March 13, 2024 | 2.457 |
| March 12, 2024 | 2.391 |
| March 11, 2024 | 2.366 |
| March 08, 2024 | 2.349 |
| March 07, 2024 | 2.440 |
| March 06, 2024 | 2.540 |
| March 05, 2024 | 2.482 |
| March 04, 2024 | 2.432 |
| March 01, 2024 | 2.424 |
| February 29, 2024 | 2.416 |
| February 28, 2024 | 2.424 |
| February 27, 2024 | 2.291 |
| February 26, 2024 | 2.242 |
| February 23, 2024 | 2.060 |
| February 22, 2024 | 2.151 |
| February 21, 2024 | 2.192 |
| February 20, 2024 | 2.267 |
| February 16, 2024 | 2.258 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5591
Minimum
Mar 30 2020
11.94
Maximum
Apr 25 2022
2.033
Average
1.632
Median
Price to Book Value Benchmarks
| Accuray Inc | 4.62 |
| Vanda Pharmaceuticals Inc | 0.5089 |
| NovaBay Pharmaceuticals Inc | 1.832 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6289 |
Price to Book Value Related Metrics
| Price | 2.94 |
| Earnings Yield | -9.86% |
| Market Cap | 202.74M |